VIM and breast cancer: ThPOK-kd led to an increase in the expression of EMT factors (VIM, SNAI2, ZEB1, ZEB2), basal markers and WNT/β-catenin target genes implicated in breast cancer cell proliferation (Fig. 3d-f) [43, 44].